
Paul W. Dickinson
Examiner (ID: 18491, Phone: (571)270-3499 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618, 1609, 4173 |
| Total Applications | 1228 |
| Issued Applications | 712 |
| Pending Applications | 114 |
| Abandoned Applications | 439 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16628579
[patent_doc_number] => 20210047232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => ANTIBACTERIAL GLASS COMPOSITION AND METHOD FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 17/049848
[patent_app_country] => US
[patent_app_date] => 2019-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049848
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049848 | ANTIBACTERIAL GLASS COMPOSITION AND METHOD FOR PREPARING SAME | Apr 18, 2019 | Pending |
Array
(
[id] => 16806178
[patent_doc_number] => 20210128731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => NANOPARTICLES FOR BORON NEUTRON CAPTURE THERAPY AND FOR DIAGNOSING, DETECTING, AND TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/047647
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047647 | NANOPARTICLES FOR BORON NEUTRON CAPTURE THERAPY AND FOR DIAGNOSING, DETECTING, AND TREATING CANCER | Apr 17, 2019 | Abandoned |
Array
(
[id] => 16340764
[patent_doc_number] => 20200305414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => AQUEOUS COMPOSITION BASED ON POLYOXYMETHYLENE DIALKYL ETHERS (POM) AND THEIR USE FOR THE PRESERVATION AND/OR EMBALMING OF THE HUMAN OR ANIMAL BODY
[patent_app_type] => utility
[patent_app_number] => 16/386584
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 270
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16386584
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/386584 | AQUEOUS COMPOSITION BASED ON POLYOXYMETHYLENE DIALKYL ETHERS (POM) AND THEIR USE FOR THE PRESERVATION AND/OR EMBALMING OF THE HUMAN OR ANIMAL BODY | Apr 16, 2019 | Abandoned |
Array
(
[id] => 16868610
[patent_doc_number] => 20210162077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => MULTIFUNCTIONAL NANOPARTICLES FOR THERAGNOSIS
[patent_app_type] => utility
[patent_app_number] => 17/265790
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265790 | MULTIFUNCTIONAL NANOPARTICLES FOR THERAGNOSIS | Apr 11, 2019 | Abandoned |
Array
(
[id] => 15035807
[patent_doc_number] => 20190328908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => IMAGEABLE EMBOLIC MICROSPHERE
[patent_app_type] => utility
[patent_app_number] => 16/381204
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/381204 | IMAGEABLE EMBOLIC MICROSPHERE | Apr 10, 2019 | Abandoned |
Array
(
[id] => 15357875
[patent_doc_number] => 10527548
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Compositions and methods for upconverting luminescence with engineered excitation and applications thereof
[patent_app_type] => utility
[patent_app_number] => 16/381974
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 33
[patent_no_of_words] => 8832
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381974
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/381974 | Compositions and methods for upconverting luminescence with engineered excitation and applications thereof | Apr 10, 2019 | Issued |
Array
(
[id] => 14960851
[patent_doc_number] => 20190307903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => METHOD FOR MANUFACTURING A BIOCOMPATIBLE FLUID COMPRISING A POWDER OF MAGNETIC PARTICLES, BIOCOMPATIBLE FLUID COMPRISING A POWDER OF MAGNETIC PARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/376297
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376297
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/376297 | METHOD FOR MANUFACTURING A BIOCOMPATIBLE FLUID COMPRISING A POWDER OF MAGNETIC PARTICLES, BIOCOMPATIBLE FLUID COMPRISING A POWDER OF MAGNETIC PARTICLES | Apr 4, 2019 | Abandoned |
Array
(
[id] => 16868340
[patent_doc_number] => 20210161807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => IMPLANTABLE DEVICE FOR LOCALIZED DRUG DELIVERY, USES AND MANUFACTURING METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/045245
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045245 | IMPLANTABLE DEVICE FOR LOCALIZED DRUG DELIVERY, USES AND MANUFACTURING METHOD THEREOF | Apr 3, 2019 | Pending |
Array
(
[id] => 14926389
[patent_doc_number] => 20190298832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => Bladder Cancer Photodynamic Therapeutic Agents with Off-On Magnetic Resonance Imaging Enhancement
[patent_app_type] => utility
[patent_app_number] => 16/372492
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16372492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/372492 | Bladder cancer photodynamic therapeutic agents with off-on magnetic resonance imaging enhancement | Apr 1, 2019 | Issued |
Array
(
[id] => 16359513
[patent_doc_number] => 20200316264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => RADIOPAQUE MATERIAL AND COMPOSITIONS AND DEVICES INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/373244
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16373244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/373244 | RADIOPAQUE MATERIAL AND COMPOSITIONS AND DEVICES INCLUDING THE SAME | Apr 1, 2019 | Abandoned |
Array
(
[id] => 16197445
[patent_doc_number] => 10722582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Targeted antimicrobial photodynamic therapy
[patent_app_type] => utility
[patent_app_number] => 16/370153
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 13201
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370153
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/370153 | Targeted antimicrobial photodynamic therapy | Mar 28, 2019 | Issued |
Array
(
[id] => 16086665
[patent_doc_number] => 20200197319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => NANOPARTICLE, PREPARATION PROCESS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/366630
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16366630
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/366630 | Nanoparticle, preparation process and uses thereof | Mar 26, 2019 | Issued |
Array
(
[id] => 15407851
[patent_doc_number] => 20200024247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => INHIBITORS OF THE IRE-1/XBP-1 PATHWAY AND METHODS OF USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/356318
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16356318
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/356318 | Inhibitors of the IRE-1/XBP-1 pathway and methods of using thereof | Mar 17, 2019 | Issued |
Array
(
[id] => 17329251
[patent_doc_number] => 11219692
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-11
[patent_title] => Porphyrin modified telodendrimers
[patent_app_type] => utility
[patent_app_number] => 16/355123
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 117
[patent_no_of_words] => 21071
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16355123
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/355123 | Porphyrin modified telodendrimers | Mar 14, 2019 | Issued |
Array
(
[id] => 14833501
[patent_doc_number] => 20190275151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => TRIPLET FUSION UPCONVERSION FOR INFRARED-SENSITIZED PHOTOREDOX CHEMISTRY
[patent_app_type] => utility
[patent_app_number] => 16/351370
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16351370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/351370 | Triplet fusion upconversion for infrared-sensitized photoredox chemistry | Mar 11, 2019 | Issued |
Array
(
[id] => 16511644
[patent_doc_number] => 20200390901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONOTHIOLATES AND - PHOSPHONATES
[patent_app_type] => utility
[patent_app_number] => 16/977680
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977680
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977680 | Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates | Mar 5, 2019 | Issued |
Array
(
[id] => 14960821
[patent_doc_number] => 20190307888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => POLYPLEX DELIVERY SYSTEM FOR PROTEINS, NUCLEIC ACIDS AND PROTEIN/NUCLEIC ACID COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 16/282174
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282174
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/282174 | Polyplex delivery system for proteins, nucleic acids and protein/nucleic acid complexes | Feb 20, 2019 | Issued |
Array
(
[id] => 16523846
[patent_doc_number] => 20200397926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/961349
[patent_app_country] => US
[patent_app_date] => 2019-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961349
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961349 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF | Jan 20, 2019 | Pending |
Array
(
[id] => 17272778
[patent_doc_number] => 20210378976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => LITHIUM FLUORIDE NANOPARTICLES FOR THE PROTECTION OF CHONDROCYTES IN OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 16/962946
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/962946 | LITHIUM FLUORIDE NANOPARTICLES FOR THE PROTECTION OF CHONDROCYTES IN OSTEOARTHRITIS | Jan 17, 2019 | Abandoned |
Array
(
[id] => 18962860
[patent_doc_number] => 11896599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Modified release preparations containing oxcarbazepine and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 16/252106
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5511
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16252106
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/252106 | Modified release preparations containing oxcarbazepine and derivatives thereof | Jan 17, 2019 | Issued |